Heidi Fields
CIK 1014330 · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
A price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FLORHAM PARK, NJ 07932
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Director | 54,122 | $7.01 | $379.4K | $0 | 7 | 2026-05-21 |
| A | Director | 112,359 | $173.89 | $19.54M | -$7.58M | 46 | 2025-03-18 |
| Icosavax, Inc. (ICVX) Delisted | Director | 0 | $15.31 | $0 | $0 | 4 | 2024-02-20 |
| AVANOS MEDICAL, INC. (AVNS) Delisted | Director | 28,855 | $24.99 | $721.1K | $0 | 3 | 2021-01-06 |
| Financial Engines, Inc. (FNGN) Delisted | Director | 21,290 | — | — | $159.9K | 16 | 2018-05-23 |
| AVANOS MEDICAL, INC. (HYH) Delisted | Director | 15,309 | — | — | $0 | 6 | 2018-05-04 |
Recent Filings · Page 6 of 9
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-06 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +4,274 | $0 | EDGAR |
| 2015-11-05 | A | Exer (M) | +8,870 | $214.2K | EDGAR |
| 2015-05-26 | Financial Engines, Inc. (FNGN) Delisted | Exer (M) | +2,504 | $0 | EDGAR |
| 2015-05-21 | Financial Engines, Inc. (FNGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-19 | Financial Engines, Inc. (FNGN) Delisted | Exer (M) | +1,250 | $0 | EDGAR |
| 2015-03-20 | A | Grant (A) | +4,311 | $182.0K | EDGAR |
| 2015-01-06 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +3,027 | $0 | EDGAR |
| 2014-11-12 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +924 | $0 | EDGAR |
| 2014-10-01 | A | Mixed | — | -$178.4K | EDGAR |
| 2014-03-21 | A | Grant (A) | +3,158 | $179.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.